Department of Pediatrics
Section of Hematology-Oncology,
Baylor College of Medicine
Dr. Andras Heczey
Texas Children’s Cancer Center
1102 Bates Street, Suite 1230.06
Houston, TX 77030
Survival of children with High Risk Neuroblastoma remains poor. For a physician treating these children, taking good care of them in the hospital is simply not enough anymore. Additional efforts must be made to find new treatments and improve the prognosis. Going back to the laboratory and working closely with other scientists is the best way to find fundamentally new approaches of treating and ultimately curing patients with High Risk neuroblastoma.
In the past year, Dr. Andras Heczey had a chance to work in the laboratory of Dr. Leonid Metelitsa on a revolutionary new approach targeting neuroblastoma cells and the tumor supporting cells in the microenvironment. The preliminary data gathered over the past year created confidence that Natural Killer T-cells are an excellent candidate for this unique approach because they can kill tumor supporting macrophages and can also eliminate neuroblastoma cells in vitro. Being involved in this groundbreaking project is critically important for a pediatric hematology and oncology fellow whose aim is to become a physician scientist.
Over the next few years, Dr. Andras Heczey’s goal is to gather critically important data that can lead to a clinical trial utilizing genetically engineered Natural Killer T-cell; a fundamentally new treatment approach to help children with high risk neuroblastoma.
Dr. Heczey is a member of the Bone Marrow Transplant (BMT) / Stem Cell Transplant Program.
M.D., Semmelweiss University, Budapest, Hungary
Residency, Children’s Hospital of Los Angeles
Fellowship, Baylor College of Medicine
Member, American Society of Clinical Oncology (ASCO)
Member, American Society of Pediatric Hematology and Oncology (ASPHO)
Member, Children’s Oncology Group (COG)
Good Student and Good Athlete of the Republic of Hungary 2000. From the Ministry of Education of Hungary
Associates and Affiliates Award of the Children’s Hospital of Los Angeles, 2009, For scientific knowledge, clinical judgment and excellence in human relations
Tumor Board Award, 2010, Texas Children’s Cancer & Hematology Centers
Chief Fellow, 2011-2012, Texas Children’s Cancer & Hematology Centers